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Containing medicines costs in the private sector
the example of a medical benefit scheme
G. HUKINS, D. SOyeE
Review of medicines utilisation and
expenditure
TABLE J. UTILISATION STATISTICS FOR MEDICINES USED
BY PRESCRIBING DOCTORS, SHOWING THE CUMULATIVE
PERCENTAGE EXPENDITURE ACCOUNTED FOR BY A
CUMULATIVE NUMBER OF PRODUCTS
accounted for approximately 60% of total benefit expenditure
in the scheme at this stage. Medicines expenditure had also
shown panicularly rapid increases in the years immediately
prior to 1986. For these reasons, medicines were identified as a
source of potential cost saving. To this end, an in-depth srudy
of trends in medicines utilisation and expenditure was under-
taken and, on the basis of this, additional' measures were
designed to reduce medicine expenditure further. This paper
reports the findings of the initial analysis and describes the
measures that were implemented and meir results.
At the time the review was undertaken, approximately 50% of
general practitioners dispensed medicines themselves, while
the remainder were 'prescribing doctors' who wrote prescrip-
tions that were dispensed by retail pharmacies. At this stage, a
limited cost-containment programme for medicines was in
operation. All doctors in the scheme were dispensing or pre-
scribing according to a limited medicines ·schedule, which was
largely, although nor entirely, based upon generic prescribing.2
Doctors were able to prescribe outside this schedule if they
believed that the clinical needs of their patients required this.
Medicines usage by doctors was actively monitored by peer
review.
A 3-month retrospective analysis of the utilisation patterns
of prescribing doctors was undenaken to ascertain the nature
and quanrities of the medicines prescribed, the cost implica-
rions of these patterns, and the extent of the utilisation of
individual retail pharmacies by members.
The analysis elicited two important findings. The first was
that a relatively small number of pharmaceutical products
accounted for a high percentage of total medicines expenditure.
As shown in Table I, the top 100 products by volume
accounted for 69,7% of total expenditure on medicines. The
second important finding was that a small number of pharma-

























Despite a pre-existing cost-containment programme, expen-
diture on medicines was identified as a source 01 further cost
savings in a medical benefit scheme faced with increasing
divergence between income and benefit expenditure. Analysis
of medicines utilisation trends showed that a relatively small
number of pharmaceutical products accounted for a high
percentage of total medicines expenditure, and that a small
number of pharmacies were dispensing a very high proportion
of prescriptions.
On the basis of these findings, a revised cost-containment
programme for medicines was implemented. It consisted of a
recommended medicines list, designed to rationalise selec-
tion and utilisation of medicines, and a 'preferred provider
pharmacy' network that allowed further savings to be
achieved.
In its first 12 months, the programme allowed for savings of
R305000, or 37% of anticipated expenditure on medicines for
that year. This represents a decrease over 1988 expenditure
notwithstanding an increase in membership and medicine
prices over the same period. There are therefore significant
savings to be obtained by medical schemes through imple-
mentation of cost-containment programmes for medicines.
S AIr Med J 1990; 78: 152-154.
Summary
The Medical Benefit Society for the Clothing Industry
(Transvaal) (referred to hereafter as 'the scheme') is a medical
benefit scheme that offers services to approximately 14000
members through a closed panel of approximately 38 general
practitioners, as well as dentists and specialists. The scheme
has always been characterised by low contribution income.
Contributions in 1986 were RI,50 per member per week
(divided equally between members and employers). This low
level (the average for all medical schemes in 1986 was R6,70
per beneficiaryl) is in line with the very low average incomes in
the industry served by the scheme (the minimum wage in 1986
was R90 per week).
During the early 1980s the scheme experienced an increasing
divergence between low and static contribution income and
rising expenditure on health services. By 1986 the scheme was
no longer able to meet expenditures out of income, and was
forced to begin utilising reserves. Since the potential for
increasing contribution income was limited, the introduction
of strenuous cost-containment measures had become an urgent
necessity.
In 1986 the average prescription COSts in this scheme were
very low compared with the average for all schemes combined
(R17,83 v. R47,12). Despite 'this, expenditure on medicines
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Results
The revised cost-containment programme for medicines was
introduced in January 1989, and was reviewed 12 months after
implementation. The programme was shown to have achieved
substantial cost savings over the period under review. Fig. 2
shows the trend in average prescription costs in the scheme as
a whole from 1983 to 1989. During the first 12 months of
operation of the programme, estimated savings of R305 000, or
37% of anticipated expendirure on medicines for that year,
were achieved. This represents a decrease of 4% over 1988
expenditure on medicines, notwithstanding an increase of 13%































The implementation of the preferred provider pharmacy
system allowed for significant additional reductions in average
prescription costs. Fig. 2 shows that by the end of 1989 the
average cost of a prescription from a preferred provider phar-
macy was 20,8% of the average for other schemes. While, for
all other schemes, the average cost per prescription increased
substantially during the 5 years before 1989, the average cost
of a prescription from a preferred provider pharmacy in this
scheme was below the scheme average for 1985.
It is also noteworthy that member support for the preferred
provider pharmacies grew significantly over the I2-month
period under review. Whereas these pharmacies had initially
accounted for 63% of all prescriptions dispensed by pharmacies,
by year-end this figure had grow to 83%.
ensure that only medicines from the list were dispensed to
members of the scheme unless doctors had specified otherwise.
They were also required to purchase sufficient stock for a 4 -
8-week period, and to take advantage of bulk packs and
quantity discounts and to pass some of these benefits onto the
" scheme.
Any pharmacy could apply to become a 'preferred provider
pharmacy'. The decision to do so, however, was likely to be
based on receiving a sufficient volume of prescriptions from
the society's members to justify the additional investment in
inventory that would be required.
Ongoing discussions as to the narure and progress of the
system were held between member representatives, the scheme









Fig. 1. Concentration of pharmacy utilisation by members.
A cost-containment programme for
medicine
for members of the scheme. Fig. 1 shows that 6 pharmacies
were responsible for dispensing 76,1% of prescriptions, which
accounted for 70,7% of medicines expenditure in the scheme
as a whole. The remaining 23,9% of prescriptions were distri-
buted among a further 84 pharmacies. These latter prescrip-
tions represented 29,3% of total medicines expenditure.
PHARMACY' ~~~~~~~
34,6% "
These observations led to the formulation of a revised cost-
containment programme consisting of two major elements.
The first involved a further rationalisation of the selection and
utilisation of medicines, through the development of a new
recommended medicines list ('the list'). The list was designed
to promote the use of a limited range of medicines that would
cost-effectively treat the majority of clinical conditions likely
to be encountered by the scheme's general practitioners and
specialists. It was compiled taking into account the existing
prescribing habits of panel doctors, and the contents of other
formularies, for example the World Health Organisation's list
of essential drugs. 3 In addition the opinions of the panel
doctors and pharmacists were elicited and taken into account
in the development of the list.
Once the list was implemented, all doctors were requested
to prescribe only from it; however, they retained the freedom
to prescribe outside it if they considered this to be in the best
interests of their patients.
All prescriptions were reviewed, and follow-up action with
practitioners was undertaken where necessary. In addition,
updating of and changes to the list were made regularly in
consultation with the panel doctors and pharmacists. Exten-
sive use was made of a computerised information system in the
development and implementation of the list. Statistics derived
from this system were regularly made available to doctors, so
as to increase awareness of their prescribing patterns 3l).d of
the cost implications of those practices to the scheme.
The second element of the programme was the development
of a system of 'preferred provider pharmacies'. This was
designed to capitalise on the concentration of pharmacy utili-
sation noted in the initial analysis. Since the majority of pre-
scriptions were being filled by six retail pharmacies, these
were invited to become preferred provider pharmacies.
The system operated as follows: members were encouraged
to use the preferred provider pharmacies through a 50%
reduction in the levy of RI per prescription payable at all
other pharmacies. In return for the guaranteed flow of cus-
tomers, and for the ability to optimise inventories on the basis
of the list, the preferred provider pharmacies were required to
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Discussion
Despite the pre-existence of a medicines schedule, medicines
expenditure accounted for a disproportionately large element
of total benefit expenditure in the scheme described here.
Although this is in part a result of the relatively low expendi-
tures on other benefits, the possibility of funher savings in the
category of medicines was correctly identified and exploited.
Several important issues should be highlighted. Firstly, the
development of a medicines list rationalised the selection and
utilisation of medicines within the scheme. The success of this
undertaking in rum depended on open, frank and effective
communication between all participants. This included the use
of a sophisticated management information system that facili-
tated communication between doctors, pharmacists and the
scheme. It also included an ongoing review of the operation of
the programme, and the introduction of modifications where
required.
The savings were greatly enhanced by the implementation
of a preferred provider pharmacy network. The list and the
preferred provider pharmacy network should therefore be seen
as mutually supportive aspects of the total programme.
An important policy throughout was to allow dOctors and
pharmacists maximum professional discretion within the un-
avoidable constraints of the cost-containment programme.
Similarly, the rights of individual members to choose a phar-
macy and a brand of medicine were retained, despite the fact
that some of these choices may have been constrained by
additional COSt implications to individuals exercising these
rights.
This programme has shown that substantial savings on
medicines expenditure are possible. Significant opponunities
for savings would appear to exist for medical schemes that
have not implemented such programmes.
We wish to acknowledge the panel doctors, the participating
pharmacists, members of the scheme, their representatives, and
the Industrial Council who gave their support for the cost-
containment programm.e described in this paper. We also thank
colleagues in the Centre for the Study of Health Policy for
editorial advice.
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Containing costs in public sector hospitals
a strategy for the future
Lessons from a large teaching hospital
0\0 "\
J. D. L. KANE-BERMAN, S. P. TAYLOR
Summary
Escalating costs of providing health care are cause for world-
wide concern. In South Africa there is increasing concern
about expenditure in the public and the private health care
sectors. Although public sector expenditure has increased in
per capita terms over the past 2 decades, at the micro-level
comparison of expenditure over a 14-year period in one
major teaching hospital region indicates that, despite in-
creasing complexity and sophistication, real costs have not
escalated at a greater rate than the consumer price index, if
extraordinary factors are discounted. The development and
utilisation of productivity and performance indicators are
reviewed and some mechanisms for containing costs in public
hospitals are discussed. These include formalised strategic
planning and allocation of resources, rationalisation and re-
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organisation of services, improved productivity and utilisation
of scarce health manpower, improved accounting and
management information systems, and the development and
use of measures of outcome. Concern is expressed regarding
excessive quantification of costs and efficiency to the detri-
ment of health care in general.
S Atr Med J 1990; 78: 154-157.
South Mrican public sector spending as a percentage of the
gross domestic product increased from 14% in 1960 to 28% in
1989 (R. P. Wronsley, Auditor-General - opening address,
8th Conference of the Epidemiological Society of Southern
Mrica, 5 - 7 July 1989). In looking for an explanation for this
substantial increase, some degree of blame is likely to be laid
at the door of what are perceived to be expensive and inappro-
priately sophisticated health services.
This paper aims to review the experience of a large teaching
hospital region in Cape Town in the present climate of severe
restriction of expenditure. Special attention will be paid to
mechanisms influencing cost escalation and cost containment.
